Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer

Clinical trial NCT06173362 · RECRUITING

Trial details

NCT number: NCT06173362
Sponsor: University of California, Davis
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Prostate Adenocarcinoma Stage III Prostate Cancer AJCC v8 Stage IV Prostate Cancer AJCC v8

Start date: 2023-11-09
Primary completion: 2026-11-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.